Generic placeholder image

Current Organic Chemistry

Editor-in-Chief

ISSN (Print): 1385-2728
ISSN (Online): 1875-5348

Research Article

Synthesis of 5-membered Heteroaryl-substituted Benzyloxy-benzaldehydes by the Suzuki-Miyaura Coupling Reaction

Author(s): Hedvig Bölcskei*, Német-Hanzelik Andrea and György Keglevich

Volume 26, Issue 18, 2022

Published on: 27 December, 2022

Page: [1725 - 1733] Pages: 9

DOI: 10.2174/1385272827666221219114255

Price: $65

Abstract

In medicinal chemistry, benzyloxy-benzaldehyde is a valuable intermediate, to which the attachment of a five membered heterocycle may be advantageous from the point of view of drug design. The starting iodo-benzyloxy-benzaldehydes were synthesized by the Obenzylation of o-, m- and p-hydroxybenzaldehydes with 2-, 3- and 4-iodobenzylbromides in refluxing acetone or acetonitrile in the presence of potassium carbonate and potassium iodide. Starting from the corresponding iodo-benzyloxy-benzaldehydes, the Suzuki-Miyaura carboncarbon cross-coupling reaction was utilized to get five membered heteroaryl-substituted benzyloxy- benzaldehydes. Various methods for Suzuki cross-coupling were studied. The applied boronic acids were 2- and 3-thiophene-boronic acids, as well as 2- and 3-furan-boronic acids. The reactions were followed by TLC and HPLC-UV-MS analysis. The products were purified by column chromatography. The original Suzuki method comprising NaOEt/EtOH, tetrakis(triphenylphosphine) palladium, in toluene was applied only in a few cases, resulting in poor yields. In several cases, the Suzuki coupling of substituted aryl iodides with 2-furanboronic acid failed to result in the formation of the expected products using the palladium acetate/tri(o-tolyl)phosphine/aqueous tripotassium phosphate/dimethoxyethan system. But reacting 3-thiophene-boronic acids with the corresponding iodo-benzyloxybenzaldehydes, this method afforded the products in 76-99% yields. The more powerful tetrakis(triphenylphosphine)palladium/aqueous cesium carbonate/ dimethylformamide system seemed to be more successful in cases of 2-thiophene boronic acid as well as 2- and 3-furan-boronic acids, providing the desired products in 75-93% yield. Twenty-six new compounds were synthesized.

« Previous
Graphical Abstract

[1]
Pevarello, P.; Bonsignori, A.; Dostert, P.; Heidempergher, F.; Pinciroli, V.; Colombo, M.; McArthur, R.A.; Salvati, P.; Post, C.; Fariello, R.G.; Varasi, M. Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives. J. Med. Chem., 1998, 41(4), 579-590.
[http://dx.doi.org/10.1021/jm970599m] [PMID: 9484507]
[2]
Xadago Summary of products characteristic UK Electronic Medicines Compendium., 2017.
[3]
Xadago (safinamide). Available from: http//:newron.com
[4]
Hayashi, Mashiro; Horie, Mashiro; Kamei, Toshio Preparation of thienyland fluorine-containing derivatives of sqalene oxidase inhibitors., JP 03157381A, 1991.
[5]
Stanforth, S.P. Catalytic cross-coupling reactions in biaryl synthesis. Tetrahedron, 1998, 54(3-4), 263-303.
[http://dx.doi.org/10.1016/S0040-4020(97)10233-2]
[6]
Bölcskei, H.; Német-Hanzelik, A.; Greiner, I.; Dubrovay, Z.; Háda, V.; Keglevich, G. The synthesis of (iodobezyloxy)benzaldehydes, useful intermediates for biologically active targets. Lett. Drug Des. Discov., 2016, 14(2), 233-239.
[http://dx.doi.org/10.2174/1570180813666160804142245]
[7]
Bölcskei, H.; Német-Hanzelik, A.; Dubrovay, Z.; Háda, V.; Keglevich, G. Synthesis of phenyl- and pyridyl-substituted benzyloxybenzaldehydes by suzuki-miyaura coupling reactions. Lett. Drug Des. Discov., 2019, 16(11), 1248-1257.
[http://dx.doi.org/10.2174/1570180816666181106123809]
[8]
Kotha, S.; Lahiri, K.; Kashinath, D. Recent applications of the Suzuki–Miyaura cross-coupling reaction in organic synthesis. Tetrahedron, 2002, 58(48), 9633-9695.
[http://dx.doi.org/10.1016/S0040-4020(02)01188-2]
[9]
Yano, J.K.; Denton, T.T.; Cerny, M.A.; Zhang, X.; Johnson, E.F.; Cashman, J.R. Synthetic inhibitors of cytochrome P-450 2A6: Inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J. Med. Chem., 2006, 49(24), 6987-7001.
[http://dx.doi.org/10.1021/jm060519r] [PMID: 17125252]
[10]
Bellina, F.; Carpita, A.; Rossi, R. Palladium catalysts for the Suzuki cross-coupling reaction: An overview of recent advances. Synthesis, 2004, (15), 2419-2440.
[11]
McClure, M.S.; Glover, B.; McSorley, E.; Millar, A.; Osterhout, M.H.; Roschangar, F. Regioselective palladium-catalyzed arylation of 2-furaldehyde. Org. Lett., 2001, 3(11), 1677-1680.
[http://dx.doi.org/10.1021/ol0158866] [PMID: 11405684]
[12]
Savarin, C.; Liebeskind, L.S. Nonbasic, room temperature, palladium-catalyzed coupling of aryl and alkenyl iodides with boronic acids mediated by copper(I) thiophene-2-carboxylate (CuTC). Org. Lett., 2001, 3(14), 2149-2152.
[http://dx.doi.org/10.1021/ol010060p] [PMID: 11440566]
[13]
Korolev, D.N.; Bumagin, N.A. An improved protocol for ligandless Suzuki–Miyaura coupling in water. Tetrahedron Lett., 2006, 47(25), 4225-4229.
[http://dx.doi.org/10.1016/j.tetlet.2006.04.039]
[14]
Rheault, T.R.; Caferro, T.R.; Dickerson, S.H.; Donaldson, K.H.; Gaul, M.D.; Goetz, A.S.; Mullin, R.J.; McDonald, O.B.; Petrov, K.G.; Rusnak, D.W.; Shewchuk, L.M.; Spehar, G.M.; Truesdale, A.T.; Vanderwall, D.E.; Wood, E.R.; Uehling, D.E. Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors. Bioorg. Med. Chem. Lett., 2009, 19(3), 817-820.
[http://dx.doi.org/10.1016/j.bmcl.2008.12.011] [PMID: 19111461]
[15]
Mahboobi, S.; Sellmer, A.; Winkler, M.; Eichhorn, E.; Pongratz, H.; Ciossek, T.; Baer, T.; Maier, T.; Beckers, T. Novel chimeric histone deacetylase inhibitors: A series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and histone deacetylase activity. J. Med. Chem., 2010, 53(24), 8546-8555.
[http://dx.doi.org/10.1021/jm100665z] [PMID: 21080629]
[16]
Hosoya, T.; Aoyama, H.; Ikemoto, T.; Kihara, Y.; Hiramatsu, T.; Endo, M.; Suzuki, M. Dantrolene analogues revisited: general synthesis and specific functions capable of discriminating two kinds of Ca2+ release from sarcoplasmic reticulum of mouse skeletal muscle. Bioorg. Med. Chem., 2003, 11(5), 663-673.
[http://dx.doi.org/10.1016/S0968-0896(02)00600-4] [PMID: 12537995]
[17]
Mitsch, A.; Wißner, P.; Silber, K.; Haebel, P.; Sattler, I.; Klebe, G.; Schlitzer, M. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides. Bioorg. Med. Chem., 2004, 12(17), 4585-4600.
[http://dx.doi.org/10.1016/j.bmc.2004.07.010] [PMID: 15358286]
[18]
Wiesner, J.; Mitsch, A.; Jomaa, H.; Schlitzer, M. Structure–activity relationships of novel anti-malarial agents. Part 7: N-(3-Benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides with polar moieties. Bioorg. Med. Chem. Lett., 2003, 13(13), 2159-2161.
[http://dx.doi.org/10.1016/S0960-894X(03)00353-6] [PMID: 12798326]
[19]
Pomel, V.; Klicic, J.; Covini, D.; Church, D.D.; Shaw, J.P.; Roulin, K.; Burgat-Charvillon, F.; Valognes, D.; Camps, M.; Chabert, C.; Gillieron, C.; Françon, B.; Perrin, D.; Leroy, D.; Gretener, D.; Nichols, A.; Vitte, P.A.; Carboni, S.; Rommel, C.; Schwarz, M.K.; Rückle, T. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase γ. J. Med. Chem., 2006, 49(13), 3857-3871.
[http://dx.doi.org/10.1021/jm0601598] [PMID: 16789742]
[20]
Kondolff, I.; Doucet, H.; Santelli, M. Suzuki coupling reactions of heteroarylboronic acids with aryl halides and arylboronic acids with heteroaryl bromides using a tetraphosphine/palladium catalyst. Synlett, 2005, 13, 2057-2061.
[21]
Kondolff, I.; Doucet, H.; Santelli, M. Palladium/tetraphosphine catalyzed suzuki cross‐coupling of heteroarylboronic acids with aryl halides. J. Heterocycl. Chem., 2008, 45(1), 109-118.
[http://dx.doi.org/10.1002/jhet.5570450109]
[22]
Langle, S.; Abarbri, M.; Duchêne, A. Selective double Suzuki cross-coupling reactions. Synthesis of unsymmetrical diaryl (or heteroaryl) methanes. Tetrahedron Lett., 2003, 44(52), 9255-9258.
[http://dx.doi.org/10.1016/j.tetlet.2003.10.080]
[23]
Alhaj Zen, A.; Aylott, J.W.; Chan, W.C. An appraisal of the Suzuki cross-coupling reaction for the synthesis of novel fluorescent coumarin derivatives. Tetrahedron Lett., 2014, 55(40), 5521-5524.
[http://dx.doi.org/10.1016/j.tetlet.2014.08.058]
[24]
Miyaura, N.; Yamada, K.; Suzuki, A. A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides. Tetrahedron Lett., 1979, 20(36), 3437-3440.
[http://dx.doi.org/10.1016/S0040-4039(01)95429-2]
[25]
Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev., 1995, 95(7), 2457-2483.
[http://dx.doi.org/10.1021/cr00039a007]
[26]
Felpin, F.X.; Ayad, T.; Mitra, S. Pd/C: an old catalyst for new applications – its use for the Suzuki- Miyaura reaction. Eur. J. Org. Chem., 2006, 2006(12), 2679-2690.
[http://dx.doi.org/10.1002/ejoc.200501004]
[27]
Bedford, R.B.; Blake, M.E.; Butts, C.P.; Holder, D. The Suzuki coupling of aryl chlorides in TBAB–water mixtures. Chem. Commun., 2003, (4), 466-467.
[http://dx.doi.org/10.1039/b211329e] [PMID: 12638952]
[28]
Novák, L.; Fekete, M.; Kolonits, P. Preparation of new vindoline derivatives by palladium-catalyzed cross coupling reactions. Heterocycles, 2005, 65(1), 165-171.
[http://dx.doi.org/10.3987/COM-04-10224]
[29]
Rossi, R.; Carpita, A.; Messeri, T. Applications of stereodefined 2-substituted 1-silyl-1-stannylethenes: A new synthesis of 5-ethenyl-5′-(1-propynyl)-2,2′-bithiophene, a naturally-occurring phototoxin. Synth. Commun., 1991, 21(18-19), 1875-1888.
[http://dx.doi.org/10.1080/00397919108021778]
[30]
Anderson, D.R.; Meyers, M.J.; Vernier, W.F.; Mahoney, M.W.; Kurumbail, R.G.; Caspers, N.; Poda, G.I.; Schindler, J.F.; Reitz, D.B.; Mourey, R.J. Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J. Med. Chem., 2007, 50(11), 2647-2654.
[http://dx.doi.org/10.1021/jm0611004] [PMID: 17480064]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy